Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 438402, 5 pages
http://dx.doi.org/10.1155/2015/438402
Review Article

Ocular Complications of Inflammatory Bowel Disease

1Department of Ophthalmology, Georgetown University, Washington Hospital Center, 3800 Reservoir Road NW, Washington, DC 20007, USA
2Department of Ophthalmology, Georgetown University and George Washington University, 900 23rd Street NW, Washington, DC 20037, USA

Received 14 January 2015; Accepted 4 March 2015

Academic Editor: Abdo Jurjus

Copyright © 2015 Rana Mady et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Fenoglio-Preiser, A. E. Noffsinger, G. N. Stemmermann, P. E. Lantz, and P. G. Isaacson, Gastrointestinal Pathology: An Atlas and Text, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 3rd edition, 2008.
  2. R. Mintz, E. Feller, R. L. Bahr, and S. A. Shah, “Ocular manifestations of inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 10, no. 2, pp. 135–139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. F. Salmon, J. P. Wright, and A. D. N. Murray, “Ocular inflammation in Crohn's disease,” Ophthalmology, vol. 98, no. 4, pp. 480–484, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Krachmer, M. J. Mannis, and E. J. Holland, Cornea, Elsevier, 3rd edition, 2011.
  5. J.-P. Hugot, P. Laurent-Puig, C. Gower-Rousseau et al., “Mapping of a susceptibility locus for Crohn's disease on chromosome 16,” Nature, vol. 379, no. 6568, pp. 821–823, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Karban, R. Eliakim, and S. R. Brant, “Genetics of inflammatory bowel disease,” Israel Medical Association Journal, vol. 4, no. 10, pp. 798–802, 2002. View at Google Scholar · View at Scopus
  7. J. H. Cho, “The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease,” Inflammatory Bowel Diseases, vol. 7, no. 3, pp. 271–275, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. R. H. Duerr, “The genetics of inflammatory bowel disease,” Gastroenterology Clinics of North America, vol. 31, no. 1, pp. 63–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Kleessen, A. J. Kroesen, H. J. Buhr, and M. Blaut, “Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls,” Scandinavian Journal of Gastroenterology, vol. 37, no. 9, pp. 1034–1041, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. E. A. Petrelli, M. McKinley, and F. J. Troncale, “Ocular manifestations of inflammatory bowel disease,” Annals of Ophthalmology, vol. 14, no. 4, pp. 356–360, 1982. View at Google Scholar · View at Scopus
  11. D. D. J. Hopkins, E. Horan, I. L. Burton, S. E. Clamp, F. T. de Dombal, and J. C. Goligher, “Ocular disorders in a series of 332 patients with Crohn's disease,” British Journal of Ophthalmology, vol. 58, no. 8, pp. 732–737, 1974. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Das, “Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis,” Digestive Diseases and Sciences, vol. 44, no. 1, pp. 1–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. E. G. Mallas, P. Mackintosh, P. Asquith, and W. T. Cooke, “Histocompatibility antigens in inflammatory bowel disease; their clinical significance and their association with arthropathy with special reference to HLA B27 (W27),” Gut, vol. 17, no. 11, pp. 906–910, 1976. View at Publisher · View at Google Scholar · View at Scopus
  14. E. K. Akpek, J. E. Thorne, F. A. Qazi, D. V. Do, and D. A. Jabs, “Evaluation of patients with scleritis for systemic disease,” Ophthalmology, vol. 111, no. 3, pp. 501–506, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. L. Knox, A. P. Schachat, and E. Mustonen, “Primary, secondary and coincidental ocular complications of Crohn's disease,” Ophthalmology, vol. 91, no. 2, pp. 163–173, 1984. View at Publisher · View at Google Scholar · View at Scopus
  16. E. B. Suhler, J. R. Smith, M. S. Wertheim et al., “A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes,” Archives of Ophthalmology, vol. 123, no. 7, pp. 903–912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. F. R. Imrie and A. D. Dick, “Biologics in the treatment of uveitis,” Current Opinion in Ophthalmology, vol. 18, no. 6, pp. 481–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ardizzone and G. B. Porro, “Biologic therapy for inflammatory bowel disease,” Drugs, vol. 65, no. 16, pp. 2253–2286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Rutgeerts, G. Van Assche, and S. Vermeire, “Optimizing anti-TNF treatment in inflammatory bowel disease,” Gastroenterology, vol. 126, no. 6, pp. 1593–1610, 2004. View at Publisher · View at Google Scholar · View at Scopus